Form4insider filings, from the source

SEC Form 4 · accession 0001225208-18-010489

PORTOLA PHARMACEUTICALS INC · PTLA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 8, 2018
Accepted (ET)
Jun 11, 2018 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001269021

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jun 8, 2018A3,000$0.00A9,000D
Common StockF3holding———45,402IBy Ltd Partnership (NEST)
Common StockF4holding———921,610IBy Ltd Partnership (SHV)
Common StockF5holding———59,053IBy Trust (Trustees)

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2,F6$42.81Jun 8, 2018A6,000A—Jun 7, 2028Common Stock6,0006,000D

Explanation of responses